H. Lundbeck

H. Lundbeck is a global pharmaceutical company that specializes in the research, development, manufacturing, and marketing of innovative treatments for brain diseases. The firm focuses on central nervous system drugs, including therapies for psychiatric and neurological disorders such as depression, schizophrenia, Alzheimer's disease, and Parkinson's disease. Lundbeck applies a dedicated scientific approach to create medicines that address complex brain disorders and improve patient outcomes.

The company was founded on August 14, 1915, by Hans Lundbeck in Copenhagen, Denmark. Initially operating as a general trading company handling various goods, it began incorporating pharmaceuticals into its product range by the mid-1920s. This gradual shift reflected an early recognition of the growing need for medical solutions, ultimately leading to its transformation into a specialized pharmaceutical entity.

Lundbeck's products serve patients worldwide who are living with debilitating brain diseases. The company's enduring mission is to be at the forefront of brain health, striving to restore brain health for every affected person. It aims to advance understanding and treatment of brain diseases, committed to transforming lives and empowering patients through its therapeutic innovations and ongoing dedication to the field.